NUVB's three largest insider shareholders as of March 23, 2026 are Fund V, L.P. Omega (TenPercentOwner, 20.46Mn shares), Oleg Nodelman (Director, 12.67Mn shares), Junyuan Jerry Wang (Ceo, Anheart Therapeutics Ltd., 3.87Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Fund V, L.P. Omega | 20,457,340 | 0 | 07 Apr, 2022 | |
| Oleg Nodelman | 0 | 12,674,775 | 22 Sep, 2023 | |
| Junyuan Jerry Wang | Ceo, Anheart Therapeutics Ltd. | 3,866,228 | 0 | 13 Nov, 2024 |
| Junyuan Jerry Wang | Ceo, Anheart Therapeutics Ltd. | 0 | 2,246,458 | 05 Sep, 2024 |
| Daniel G Welch | 659,947 | 0 | 29 May, 2024 | |
| Robert Mashal | 0 | 200,000 | 03 Apr, 2025 | |
| Colleen Sjogren | Chief Commercial Officer | 81,000 | 0 | 18 Jun, 2025 |
| Moses Makunje | See Remarks | 68,137 | 0 | 03 Mar, 2026 |
| Kerry Wentworth | Chief Regulatory Officer | 50,000 | 0 | 18 Jun, 2025 |
| Stacy Markel | Chief People Officer | 29,591 | 0 | 18 Jun, 2025 |
| David C. Hanley | Chief Technical Operations | 24,000 | 0 | 21 Nov, 2025 |
| Dongfang Liu | Chief Medical Officer | 18,000 | 0 | 03 Dec, 2025 |
| Philippe Sauvage | Chief Financial Officer | 9,902 | 0 | 18 Jun, 2025 |
| Robert B Bazemore | 5,000 | 0 | 01 Apr, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 27 Feb, 2026 | Dongfang Liu | Stock Option (Right to Buy) | A | 748,130 | $0.00 | 748,130 | D | A |
| 27 Feb, 2026 | David C. Hanley | Stock Option (Right to Buy) | A | 748,130 | $0.00 | 748,130 | D | A |
| 27 Feb, 2026 | Moses Makunje | Class A Common Stock | A | 50,761 | $0.00 | 68,137 | D | A |
| 27 Feb, 2026 | Philippe Sauvage | Stock Option (Right to Buy) | A | 748,130 | $0.00 | 748,130 | D | A |
| 27 Feb, 2026 | Stacy Markel | Stock Option (Right to Buy) | A | 748,130 | $0.00 | 748,130 | D | A |
| 27 Feb, 2026 | Moses Makunje | Stock Option (Right to Buy) | A | 224,439 | $0.00 | 224,439 | D | A |
| 27 Feb, 2026 | Kerry Wentworth | Stock Option (Right to Buy) | A | 748,130 | $0.00 | 748,130 | D | A |
| 27 Feb, 2026 | Colleen Sjogren | Stock Option (Right to Buy) | A | 748,130 | $0.00 | 748,130 | D | A |
| 01 Dec, 2025 | Dongfang Liu | Class A Common Stock | A | 150,000 | $2.93 | 168,000 | D | M |
| 01 Dec, 2025 | Dongfang Liu | Class A Common Stock | D | 150,000 | $7.82 | 18,000 | D | S |
| 01 Dec, 2025 | Dongfang Liu | Stock Option (Right to Buy) | D | 150,000 | $0.00 | 165,000 | D | M |
| 25 Nov, 2025 | Dongfang Liu | Class A Common Stock | A | 10,000 | $3.61 | 28,000 | D | M |
| 25 Nov, 2025 | Dongfang Liu | Class A Common Stock | D | 10,000 | $7.50 | 18,000 | D | S |
| 26 Nov, 2025 | Dongfang Liu | Class A Common Stock | A | 10,000 | $3.61 | 28,000 | D | M |
| 26 Nov, 2025 | Dongfang Liu | Class A Common Stock | D | 10,000 | $8.00 | 18,000 | D | S |
| 25 Nov, 2025 | Dongfang Liu | Stock Option (Right to Buy) | D | 10,000 | $0.00 | 480,000 | D | M |
| 26 Nov, 2025 | Dongfang Liu | Stock Option (Right to Buy) | D | 10,000 | $0.00 | 470,000 | D | M |
| 20 Nov, 2025 | Dongfang Liu | Class A Common Stock | A | 20,000 | $1.87 | 38,000 | D | M |
| 20 Nov, 2025 | Dongfang Liu | Class A Common Stock | D | 20,000 | $7.00 | 18,000 | D | S |
| 20 Nov, 2025 | Dongfang Liu | Stock Option (Right to Buy) | D | 20,000 | $0.00 | 450,000 | D | M |